|
FR3066393A1
|
|
Active ingredient composed by a mixture of poly-lysine compounds and use in avoid prevention and treatment of the post-avc inflammatory phase
|
|
FR3024775A1
|
|
Process for identifying and characterizing polypeptide compounds
|
|
FR2905868A1
|
|
Composition for the treatment of amyotrophic lateral sclerosis
|
|
CA2609369A1
|
|
Composition for the treatment of multiple sclerosis
|
|
WO2006051241A2
|
|
Method for coupling non-immunogenic molecules, intermediate compound, final product obtained and uses thereof
|
|
WO2004058856A1
|
|
Method for the production of a molecule vector applicable in the field of water treatment and vector thus obtained
|
|
FR2849043A1
|
|
Method for manufacturing an active molecule vector applicable in the field of diffusion of active principles and vector obtained
|
|
FR2822238A1
|
|
Method and kit for monitoring neurodegenerative diseases
|
